Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124969302 | 12496930 | 2 | F | 20160126 | 20160802 | 20160624 | 20160812 | EXP | JP-UCBSA-2016022496 | UCB | 90.70 | YR | M | Y | 0.00000 | 20160812 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124969302 | 12496930 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Intravenous drip | 500 MG, ONCE DAILY (QD) | 500 | MG | 21035 | 500 | MG | QD | |||||
| 124969302 | 12496930 | 2 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Intravenous drip | 250 MG, 2X/DAY (BID) | 500 | MG | 21035 | 250 | MG | BID | |||||
| 124969302 | 12496930 | 3 | SS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Intravenous drip | 250 MG, ONCE DAILY (QD) | 500 | MG | 21035 | 250 | MG | QD | |||||
| 124969302 | 12496930 | 4 | C | ARTANE | TRIHEXYPHENIDYL HYDROCHLORIDE | 1 | Oral | 2 MG, | U | 0 | 2 | MG | TABLET | ||||||
| 124969302 | 12496930 | 5 | C | Itorol | ISOSORBIDE MONONITRATE | 1 | Oral | 40 MG, | U | 0 | 40 | MG | TABLET | ||||||
| 124969302 | 12496930 | 6 | C | Bup-4 | PROPIVERINE | 1 | Oral | 20 MG, | U | 0 | 20 | MG | TABLET | ||||||
| 124969302 | 12496930 | 7 | C | BUFFERIN | ASPIRIN | 1 | Oral | 81 MG, ONCE DAILY (QD) | U | 0 | 81 | MG | TABLET | QD | |||||
| 124969302 | 12496930 | 8 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, UNK | U | 0 | 10 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124969302 | 12496930 | 1 | Partial seizures with secondary generalisation |
| 124969302 | 12496930 | 2 | Dyskinesia |
| 124969302 | 12496930 | 3 | Off label use |
| 124969302 | 12496930 | 4 | Product used for unknown indication |
| 124969302 | 12496930 | 5 | Product used for unknown indication |
| 124969302 | 12496930 | 6 | Product used for unknown indication |
| 124969302 | 12496930 | 7 | Product used for unknown indication |
| 124969302 | 12496930 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124969302 | 12496930 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124969302 | 12496930 | Hospitalisation | |
| 124969302 | 12496930 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124969302 | 12496930 | 1 | 20160126 | 20160126 | 0 | |
| 124969302 | 12496930 | 2 | 20160129 | 20160129 | 0 | |
| 124969302 | 12496930 | 3 | 20160130 | 20160130 | 0 | |
| 124969302 | 12496930 | 4 | 20160126 | 20160129 | 0 | |
| 124969302 | 12496930 | 5 | 20160129 | 0 | ||
| 124969302 | 12496930 | 6 | 20160129 | 0 | ||
| 124969302 | 12496930 | 7 | 20160129 | 0 | ||
| 124969302 | 12496930 | 8 | 20160129 | 0 |